Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Viral Immunology
|
October 1, 2016
Immunovirological Efficacy of Once-Daily Maraviroc Plus Ritonavir-Boosted Atazanavir After 48 Weeks in Naive HIV-Infected Patients
Ildefonso Pulido, Miguel Genebat, Ana I Alvarez-Rios, et al.
AIDS (London, England)
|
March 17, 2018
Role of toll-like receptor 4 Asp299Gly polymorphism in the development of cardiovascular diseases in HIV-infected patients
Laura Tarancon-Diez, Rebeca S De Pablo-Bernal, José L Jiménez, et al.
Antiviral Research
|
July 1, 2015
Maraviroc Clinical Test (MCT) as an alternative tool to decide CCR5-antagonists prescription in naïve HIV-infected patients
Miguel Genebat, Rebeca S de Pablo-Bernal, Ildefonso Pulido, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
September 21, 2014
IFNγ⁻TNFα⁻IL2⁻MIP1α⁻CD107a⁺PRF1⁺ CD8 pp65-Specific T-Cell Response Is Independently Associated With Time to Death in Elderly Humans
Sara Ferrando-Martínez, Ezequiel Ruiz-Mateos, Joseph P Casazza, et al.
Thrombosis and Haemostasis
|
March 10, 2017
CCR5+ CD8 T-cell levels and monocyte activation precede the onset of acute coronary syndrome in HIV-infected patients on antiretroviral therapy
Laura Tarancon-Diez, Rebeca S De Pablo-Bernal, Ana I Álvarez-Rios, et al.
Plos One
|
March 6, 2014
Reduced sTWEAK and increased sCD163 levels in HIV-infected patients: modulation by antiretroviral treatment, HIV replication and HCV co-infection
Luis M Beltrán, Rocío Muñoz Hernández, Rebeca S de Pablo Bernal, et al.
Antiviral Research
|
September 1, 2014
Maintenance of virologic efficacy and decrease in levels of β2-microglobulin, soluble CD40L and soluble CD14 after switching previously treated HIV-infected patients to an NRTI-sparing dual therapy
M Concepción Romero-Sánchez, Ana I Alvarez-Ríos, Enrique Bernal-Morell, et al.
Antimicrobial Agents and Chemotherapy
|
June 24, 2020
Modulation of Monocyte Activation and Function during Direct Antiviral Agent Treatment in Patients Coinfected with HIV and Hepatitis C Virus
Rebeca S De Pablo-Bernal, M Reyes Jimenez-Leon, Laura Tarancon-Diez, et al.
Antiviral Research
|
March 28, 2017
Higher levels of IL-6, CD4 turnover and Treg frequency are already present before cART in HIV-infected subjects with later low CD4 recovery
Isaac Rosado-Sánchez, Inmaculada Jarrín, María M Pozo-Balado, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 4, 2017
Thymic Function Failure Is Associated With Human Immunodeficiency Virus Disease Progression
Sara Ferrando-Martinez, Rebeca S De Pablo-Bernal, Marta De Luna-Romero, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Viral Immunology
|
October 1, 2016
Immunovirological Efficacy of Once-Daily Maraviroc Plus Ritonavir-Boosted Atazanavir After 48 Weeks in Naive HIV-Infected Patients
Ildefonso Pulido, Miguel Genebat, Ana I Alvarez-Rios, et al.
AIDS (London, England)
|
March 17, 2018
Role of toll-like receptor 4 Asp299Gly polymorphism in the development of cardiovascular diseases in HIV-infected patients
Laura Tarancon-Diez, Rebeca S De Pablo-Bernal, José L Jiménez, et al.
Antiviral Research
|
July 1, 2015
Maraviroc Clinical Test (MCT) as an alternative tool to decide CCR5-antagonists prescription in naïve HIV-infected patients
Miguel Genebat, Rebeca S de Pablo-Bernal, Ildefonso Pulido, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
September 21, 2014
IFNγ⁻TNFα⁻IL2⁻MIP1α⁻CD107a⁺PRF1⁺ CD8 pp65-Specific T-Cell Response Is Independently Associated With Time to Death in Elderly Humans
Sara Ferrando-Martínez, Ezequiel Ruiz-Mateos, Joseph P Casazza, et al.
Thrombosis and Haemostasis
|
March 10, 2017
CCR5+ CD8 T-cell levels and monocyte activation precede the onset of acute coronary syndrome in HIV-infected patients on antiretroviral therapy
Laura Tarancon-Diez, Rebeca S De Pablo-Bernal, Ana I Álvarez-Rios, et al.
Plos One
|
March 6, 2014
Reduced sTWEAK and increased sCD163 levels in HIV-infected patients: modulation by antiretroviral treatment, HIV replication and HCV co-infection
Luis M Beltrán, Rocío Muñoz Hernández, Rebeca S de Pablo Bernal, et al.
Antiviral Research
|
September 1, 2014
Maintenance of virologic efficacy and decrease in levels of β2-microglobulin, soluble CD40L and soluble CD14 after switching previously treated HIV-infected patients to an NRTI-sparing dual therapy
M Concepción Romero-Sánchez, Ana I Alvarez-Ríos, Enrique Bernal-Morell, et al.
Antimicrobial Agents and Chemotherapy
|
June 24, 2020
Modulation of Monocyte Activation and Function during Direct Antiviral Agent Treatment in Patients Coinfected with HIV and Hepatitis C Virus
Rebeca S De Pablo-Bernal, M Reyes Jimenez-Leon, Laura Tarancon-Diez, et al.
Antiviral Research
|
March 28, 2017
Higher levels of IL-6, CD4 turnover and Treg frequency are already present before cART in HIV-infected subjects with later low CD4 recovery
Isaac Rosado-Sánchez, Inmaculada Jarrín, María M Pozo-Balado, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 4, 2017
Thymic Function Failure Is Associated With Human Immunodeficiency Virus Disease Progression
Sara Ferrando-Martinez, Rebeca S De Pablo-Bernal, Marta De Luna-Romero, et al.
Page
of 1